XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Liabilities Measured on Recurring Basis
The following table presents our assets and liabilities measured at fair value on a recurring basis at March 31, 2023:

  Fair Value Measurements at 
March 31, 2023
TotalQuoted
Prices
in Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Liabilities:
Ionic convertible debenture derivative$(24,000)$— $— $(24,000)
LINICO related derivative(5,468,162)— (5,468,162)— 
Haywood derivative(1,190,000)— (1,190,000)— 
GenMat derivative(5,234,043)— (5,234,043)— 
Total liabilities measured at fair value$(11,916,205)$— $(11,892,205)$(24,000)
The following table presents our assets and liabilities at December 31, 2022, measured at fair value on a recurring basis:
  Fair Value Measurements at
December 31, 2022
TotalQuoted
Prices
in Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Liabilities:
Ionic convertible debenture derivative$(420,000)$— $— $(420,000)
LINICO related derivative (6,053,162)— (6,053,162)— 
Haywood derivative(1,480,000)— (1,480,000)— 
GenMat derivative(6,592,638)— (6,592,638)— 
Total liabilities measured at fair value$(14,545,800)$— $(14,125,800)$(420,000)